Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$119.57 - $139.07 $1.02 Million - $1.19 Million
-8,540 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$109.17 - $142.35 $46,397 - $60,498
-425 Reduced 4.74%
8,540 $1.14 Million
Q1 2021

Apr 29, 2021

SELL
$101.51 - $125.27 $40,604 - $50,108
-400 Reduced 4.27%
8,965 $944,000
Q4 2020

Jan 29, 2021

SELL
$85.88 - $105.36 $30,745 - $37,718
-358 Reduced 3.68%
9,365 $975,000
Q3 2020

Oct 28, 2020

BUY
$72.74 - $92.5 $86,924 - $110,537
1,195 Added 14.01%
9,723 $833,000
Q2 2020

Jul 28, 2020

SELL
$48.02 - $79.04 $51,861 - $85,363
-1,080 Reduced 11.24%
8,528 $625,000
Q1 2020

Apr 30, 2020

SELL
$36.95 - $62.95 $7,168 - $12,212
-194 Reduced 1.98%
9,608 $499,000
Q4 2019

Jan 29, 2020

SELL
$47.06 - $56.64 $6,682 - $8,042
-142 Reduced 1.43%
9,802 $552,000
Q3 2019

Oct 31, 2019

SELL
$47.45 - $58.05 $643,659 - $787,448
-13,565 Reduced 57.7%
9,944 $474,000
Q2 2019

Jul 31, 2019

SELL
$39.26 - $54.21 $15.4 Million - $21.2 Million
-391,139 Reduced 94.33%
23,509 $1.27 Million
Q1 2019

May 01, 2019

SELL
$29.84 - $43.92 $609,452 - $897,022
-20,424 Reduced 4.69%
414,648 $16.8 Million
Q4 2018

Jan 30, 2019

SELL
$29.95 - $46.34 $192,548 - $297,919
-6,429 Reduced 1.46%
435,072 $13.6 Million
Q3 2018

Oct 31, 2018

SELL
$40.12 - $45.55 $3.75 Million - $4.26 Million
-93,487 Reduced 17.47%
441,501 $20.1 Million
Q2 2018

Jul 31, 2018

SELL
$38.72 - $42.52 $5.7 Million - $6.25 Million
-147,100 Reduced 21.57%
534,988 $22.4 Million
Q1 2018

Apr 26, 2018

SELL
$39.4 - $47.39 $1.62 Million - $1.95 Million
-41,049 Reduced 5.68%
682,088 $28 Million
Q4 2017

Feb 05, 2018

BUY
$37.27 - $43.02 $4.43 Million - $5.12 Million
118,930 Added 19.68%
723,137 $29.7 Million
Q3 2017

Oct 30, 2017

BUY
$33.75 - $41.67 $20.4 Million - $25.2 Million
604,207
604,207 $24.1 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.